TMEM22 peptides and vaccines including the same

Details for Australian Patent Application No. 2010331648 (hide)

Owner Oncotherapy Science, Inc.

Inventors Nakamura, Yusuke; Tsunoda, Takuya; Ohsawa, Ryuji; Yoshimura, Sachiko; Watanabe, Tomohisa

Agent Davies Collison Cave

Pub. Number AU-A-2010331648

PCT Pub. Number WO2011/074236

Priority 61/326,380 21.04.10 US; 61/287,650 17.12.09 US; 61/286,213 14.12.09 US

Filing date 13 December 2010

Wipo publication date 23 June 2011

International Classifications

C07K 7/06 Peptides having 5 to 20 amino acids in a fully defined sequence

C12N 5/0781 Undifferentiated human, animal or plant cells, e.g. cell lines - B cells

C12N 5/0783 Undifferentiated human, animal or plant cells, e.g. cell lines - T cells

C12N 5/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 Mutation or genetic engineering - Recombinant DNA-technology

Event Publications

21 June 2012 PCT application entered the National Phase

  PCT publication WO2011/074236 Priority application(s): WO2011/074236

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010331712-Air conditioner

2010331575-Cutting blade clutch for mower